Assertio Therapeutics Inc. (ASRT)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q3 2023 | |||||
| ≡ | First Eagle Investment Management | Sell 100.00% | 1,037,604 | 0.01 | |
| Q2 2023 | |||||
| ≡ | First Eagle Investment Management | Add 20.66% | 177,650 | 0.00 | |
| Q1 2023 | |||||
| ≡ | First Eagle Investment Management | Add 24.98% | 171,879 | 0.00 | |
| Q4 2022 | |||||
| ≡ | First Eagle Investment Management | Add 37.62% | 188,076 | 0.00 | |
| Q3 2022 | |||||
| ≡ | First Eagle Investment Management | Add 99.96% | 249,946 | 0.00 | |
| Q2 2022 | |||||
| ≡ | First Eagle Investment Management | Buy | 250,053 | 0.00 | |
| Q2 2020 | |||||
| ≡ | Howard Marks - Oaktree Capital Management | Sell 100.00% | 1,492,455 | 0.03 | |
| Q3 2019 | |||||
| ≡ | Howard Marks - Oaktree Capital Management | Buy | 1,492,455 | 0.05 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.